Karimah Es Sabar named Quark Venture's new CEO and partner
Canadian life sciences venture capital firm Quark Venture has appointed Karimah Es Sabar as CEO and partner. Previously, Es Sabar was the president and CEO of the Centre for Drug Research and Development, a Vancouver-based drug development and commercialization centre. Founded last year, Vancouver's Quark Venture provides equity financing to biotechnology and health sciences companies. To date, the firm has invested in Aurora Lifesciences Corp and Sitka Biopharma.
20 September 2016•3 mins read
